Director Chen Guiling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Chen Guiling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Chen Guiling Today - Breaking & Trending Today

Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance

Published: January 12, 2022

HANGZHOU, CHINA, Jan 12, 2022 - (ACN Newswire) - On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report on the analysis results of the phase I clinical trial data of its mRNA

Source: finanznachrichten.de

Related Topics:

Wang YuZeng GuangShan ChaoPeng YucaiKostenloser WertpapierhandelQin XiaofengXiong ChangyunSystems Research CenterInstitutes Of Biomedical Sciences Xu JianqingChinese CenterFudan UniversitySuzhou Institute Of Systems MedicineTsinghua UniversityVanke School Of Public HealthWuhan Institute Of VirologyDirector Chen GuilingPhasei Clinical Trial LaboratoryWuhan InstituteVanke SchoolPublic HealthDisease ControlBiomedical Sciences Xu JianqingBasic Medical SciencesChinese AcademyMedical Sciences

Phase I Clinical Trial Of Aim Mrna Covid-19 Vaccine (lvrna009)

Published: January 12, 2022

Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance

Source: briefingwire.com

Related Topics:

Wang YuZeng GuangShan ChaoPeng YucaiMrna CovidFudan UniversityChinese CenterInstitutes Of Biomedical Sciences Xu JianqingTsinghua UniversityWuhan Institute Of VirologyVanke School Of Public HealthClinical Trial Of Aim MrnaClinical TrialHigh SafetyDirector Chen GuilingPhasei Clinical Trial LaboratoryWuhan InstituteVanke SchoolPublic HealthDisease ControlBiomedical Sciences Xu JianqingPress ReleasePress ReleasesRee Press ReleaseRee Press Releases